Summary & Overview
HCPCS G8929: Adjuvant Chemotherapy Not Prescribed or Previously Received
HCPCS Level II code G8929 identifies encounters where adjuvant chemotherapy was not prescribed or previously received and no reason was recorded. Nationally, this code matters for tracking gaps in guideline-directed cancer care documentation, quality measurement, and administrative reporting. Accurate use of G8929 affects clinical registries, quality programs, and payer reviews focused on cancer care completeness and care coordination.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical meaning, typical service setting, and implications for billing and quality measurement. The publication outlines benchmark considerations where available, common documentation issues that prompt use of the code, and any relevant policy context that affects national reporting and audits.
This piece emphasizes practical informational context rather than clinical recommendations. It is intended for coding specialists, oncology billing managers, clinical documentation improvement teams, and payer policy analysts seeking a clear, national-level understanding of G8929 and its role in cancer care documentation and administrative workflows.
Billing Code Overview
HCPCS Level II code G8929 denotes adjuvant chemotherapy not prescribed or previously received, reason not given. This code captures cases in which a patient with an indication for adjuvant chemotherapy has not been prescribed or has not previously received adjuvant chemotherapy, and no specific reason for omission is documented.
Service type: Oncology follow-up/chemotherapy care decision documentation
Typical site of service: Outpatient oncology clinic or ambulatory care setting
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a recent primary diagnosis of breast, colorectal, lung, or other solid-organ malignancy who has completed definitive local therapy (surgery ± radiation) and is being evaluated for adjuvant systemic therapy. During a multidisciplinary post-operative oncology visit, the medical oncologist documents that adjuvant chemotherapy was not prescribed or previously received and the reason was not recorded in the chart. The clinical workflow includes review of pathology and staging, discussion of risks/benefits of chemotherapy, assessment of performance status/comorbidities, consideration of genomic testing results, and shared decision-making. The visit is coded with G8929 when the encounter specifically records that adjuvant chemotherapy was not prescribed or previously received but no reason is provided, typically as part of administrative reporting or quality measure abstraction. Typical sites of service include outpatient oncology clinic and hospital outpatient department. Typical encounter roles involve the medical oncologist, oncology nurse navigator, and clinic documentation staff responsible for quality reporting abstraction.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure | Use when a distinct E/M visit occurs the same day as a minor procedure related to oncology care |